ArticleBMC cancer2021

Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data.

Margaret von Mehren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.